Abingdon Health (LON:ABDX) Hits New 1-Year High – Here’s Why

Abingdon Health Plc (LON:ABDX) shares hit a new 52-week high during trading on Wednesday . The company traded as high as GBX 9 and last traded at GBX 9, with a volume of 294507 shares changing hands. The stock had previously closed at GBX 8.75.

Abingdon Health Price Performance

The stock has a market capitalization of £22.35 million, a price-to-earnings ratio of -10.99 and a beta of 0.25. The company’s 50-day simple moving average is GBX 7.40 and its 200-day simple moving average is GBX 6.81. The company has a debt-to-equity ratio of 15.05, a current ratio of 1.91 and a quick ratio of 1.96.

Abingdon Health (LON:ABDX) last posted its earnings results on Tuesday, March 17th. The company reported GBX (0.43) EPS for the quarter. Abingdon Health had a negative net margin of 33.88% and a negative return on equity of 55.91%.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.